1. Risk factors for the development or progression of diabetic retinopathy in pregnancy: Meta-analysis and systematic review;Sarvepalli;Clin Experiment Ophthalmol,2023
2. GLP-1R as a target for the treatment of diabetic retinopathy: Friend or foe?;Simó;Diabetes,2017
3. Global prevalence of diabetic retinopathy and projection of burden through 2045;Teo;Ophthalmology,2021
4. GLP-1 receptor agonists: A review of head-to-head clinical studies;Trujillo;Ther Adv Endocrinol Metab,2015
5. Endocrinology Network. Tirzepatide (Mounjaro) wins FDA approval for type 2 diabetes. Available at: https://www.endocrinologynetwork.com/view/tirzepatide-wins-fda-approval-for-type-2-diabetes. Accessed August 29, 2022.